The AMR Patient Alliance is a global coalition of patient advocacy organisations from various countries, including Australia, Canada, India, the United Kingdom, and Macedonia
Since its establishment, IAPO and IAPO P4PS Observatory are dedicated to fighting antimicrobial resistance (AMR), through development of policy briefs, analyses, educational materials and advocacy toolkits for its members and patient organisations worldwide.
The UN has called for concerted action from governments and various sectors to address the implications of AMR in a comprehensive manner, and implement strategies at national level.
However, the practice is showing us that patients need to play a much bigger role in this fight, as they are directly involved in over-prescribing, overuse and self-medication, the scale and effect of which is still unknown.
There are many organisations interested in the issue of AMR, and the diversity of expertise and experience is vast. However, to date, there has been no consolidated effort globally to amalgamate these and provide a coherent guidance and support for patients’ engagement in tackling this global public health threat.
The commitment and a vision of several civil society organisations to overcome this disconnect, and gather the voice of patients around the issue of antimicrobial resistance (AMR) has grown into the AMR Patient Alliance.
The AMR Patient Alliance is created with a vision of a world where human-induced antimicrobial resistance is eliminated.
Its mission is to work on patient empowerment, literacy and engagement for preserving the effectiveness of antibiotics, so that they can be accessible and effective for as long as possible for the future generations.
Involvement of all stakeholders, and in particular patient groups, patients and caregivers is critical. The AMR Patient Alliance will welcome individuals, organisations and all stakeholders who wish to contribute to the achievement of this vision.